Drivetime Specialty is a free educational audio program covering a range of topics relevant to various medical specialists & physicians. Listen to our experienced medical broadcasters, moderating engaging discussions with leading experts.
Current disciplines include:
A podcast of the specialty series is available to download, providing a time efficient form of communication that’s convenient and easy to consume. Click here for podcast download instructions You can also listen online – search by your area of interest to filter interviews relevant to you.
Interviews are provided exclusively for Australian healthcare professionals. Subscribe for free today to access all programs.
NEW Respiratory. There are now three biologic agents for severe refractory asthma available in Australia. These agents when chosen appropriately can improve asthma control and decrease the risk of exacerbations. We need to ensure that these therapies are given to the right sort of patient, so what factors do we need to consider?
NEW Neurology. Making a diagnosis of epilepsy can be difficult, particularly establishing the difference between focal and generalised seizures, and this differential is critical. In this interview we discuss this, as well as how to ensure the patient gets the right treatment, early on.
NEW Neurology. One of the most difficult areas of practice for neurologists are the rules and regulations around driving with epilepsy. There’s a lot of confusion and immense interest in this topic, so in this interview we discuss the social consequences and the practical issues.
NEW Ophthalmology. Led by Diabetes Australia and Vision 2020 Australia, the NEW KeepSight initiative will engage with 1.27 million people with diabetes who are registered on the National Diabetes Services Scheme (NDSS). How will the KeepSight program ultimately change the management of diabetic retinopathy in Australia, and what do you as ophthalmologists need to do?
NEW Ophthalmology. New screening programs in Australia will help improve the detection rates of diabetic retinopathy, leading to earlier detection and treatment. Early detection and treatment can prevent the majority of vision loss and blindness in patients with diabetes, so how can we shift the care from what is now, very expensive hospital-based care, where ophthalmologists need laser treatment and intensive anti-VEFG injections, towards more primary and secondary care?
NEW Psychiatry. People with psychotic disorders have high levels of co-morbidity and sadly their life expectancy is reduced by 10-25 years. Thinking long-term from the beginning is key, so in the first part of this interview we discuss the efficacy across all current treatments and the side effect profile, including short-term effects such as sedation and long-term concerns with weight and particularly metabolic functioning.
NEW Psychiatry. We now have more options within the atypical antipsychotic range, so in the second part of this interview with Cristoph Correll, we discuss the evidence for effective medications that also have relatively little cardiometabolic burden.
NEW Psychiatry. In this interview we discuss the link between depression and altered circadian rhythm, plus the role of melatonergic receptors and 5HT-2C receptors in the regulation of circadian rhythm and the treatment of depression.
NEW Psychiatry. Identifying symptoms of depression and patient willingness to start treatment are key challenges to effective treatment. Patient preference, as well as the features of the episode are important considerations, so we talk to both a patient and David Horgan about patient-centred care for depression.
NEW Respiratory. The first interview in this new series discusses ‘The Salford Lung Study’, one of the largest studies in asthma ever conducted in primary care. We discuss the design and key findings with the chief investigator, Dr David Leather, so you can stay up-to-date on the go.
Tap the share icon and select 'Add to Home Screen' to add the site to your home screen for quick access!